Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Key Highlights
- ➤First-ever U.S. TRD Awareness Day launched with NAMI, MHA and DBSA support
- ➤Approximately 4 million U.S. patients have treatment-resistant depression
- ➤Nearly 95% of surveyed TRD patients report functioning but struggling or worse
- ➤Nearly two-thirds of caregivers say TRD affects the whole family’s health
- ➤Compass is evaluating investigational COMP360 psilocybin in late-stage TRD and PTSD trials
Expert Statements
Leah Wentworth, PhD, National Director of Science and Research, NAMI
“For too many people living with TRD, the daily challenges of the condition are compounded by feeling misunderstood, judged or even blamed when treatments don’t work.”
Leah Wentworth, PhD, National Director of Science and Research, NAMI
“TRD’s impact extends to their families and caregivers as they help their loved ones navigate the condition.”
Leah Wentworth, PhD, National Director of Science and Research, NAMI
“As we recognize the first TRD Awareness Day, we have an important opportunity to bring greater visibility to this community, challenge the stigma and misunderstanding surrounding TRD, and remind those affected that they are not alone.”
Steve Levine, M.D., Chief Patient Officer, Compass Pathways
“People living with treatment-resistant depression deserve to know that their experiences are recognized, their voices matter and there are people working alongside them to drive meaningful change.”
Steve Levine, M.D., Chief Patient Officer, Compass Pathways
“At Compass, we are deeply committed to the TRD community and to elevating the experiences of patients and caregivers as we work to address the significant unmet needs that remain.”
Steve Levine, M.D., Chief Patient Officer, Compass Pathways
“By bringing greater awareness to TRD, we can help build a future where people facing this condition feel understood, better supported and more hopeful about what may be possible.”
Sagar V. Parikh, M.D., FRCPC, DBSA Scientific Advisory Board Vice Chair
“When depression continues despite multiple treatment attempts, many people do not realize they may be experiencing TRD.”
Sagar V. Parikh, M.D., FRCPC, DBSA Scientific Advisory Board Vice Chair
“TRD Awareness Day can help both patients and clinicians better understand that this is a distinct condition, separate from major depressive disorder and recognize when it may be time to ask different questions about care strategies.”
Sagar V. Parikh, M.D., FRCPC, DBSA Scientific Advisory Board Vice Chair
“Greater awareness is an important step towards helping people find the support they need and deserve.”
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
* First-ever Treatment-Resistant Depression (TRD) Awareness Day establishes dedicated moment to recognize and raise awareness of the condition’s profound impact on patients and their loved ones
Get started
Create a free account to read the full story.